Insufficient scRNA-seq data for expression of MAGEL2 at single-cell level.
Insufficient scRNA-seq data for expression of MAGEL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 85% | 594.72 | 2238 / 2642 | 92% | 5.35 | 646 / 705 |
pancreas | 88% | 93.04 | 289 / 328 | 58% | 1.77 | 103 / 178 |
ovary | 99% | 377.47 | 178 / 180 | 38% | 1.68 | 165 / 430 |
thymus | 92% | 130.13 | 603 / 653 | 34% | 1.00 | 203 / 605 |
breast | 73% | 65.08 | 334 / 459 | 38% | 0.73 | 430 / 1118 |
uterus | 94% | 298.05 | 160 / 170 | 16% | 2.80 | 73 / 459 |
prostate | 68% | 53.00 | 166 / 245 | 33% | 0.81 | 166 / 502 |
eye | 0% | 0 | 0 / 0 | 78% | 2.56 | 62 / 80 |
adrenal gland | 26% | 24.87 | 67 / 258 | 48% | 8.19 | 110 / 230 |
skin | 24% | 21.32 | 430 / 1809 | 38% | 3.07 | 180 / 472 |
spleen | 61% | 59.50 | 148 / 241 | 0% | 0 | 0 / 0 |
adipose | 57% | 45.28 | 685 / 1204 | 0% | 0 | 0 / 0 |
intestine | 50% | 34.54 | 479 / 966 | 7% | 0.20 | 38 / 527 |
bladder | 33% | 25.33 | 7 / 21 | 11% | 0.49 | 57 / 504 |
stomach | 29% | 19.16 | 103 / 359 | 11% | 0.28 | 31 / 286 |
lung | 18% | 11.24 | 105 / 578 | 14% | 0.39 | 160 / 1155 |
esophagus | 17% | 9.83 | 246 / 1445 | 15% | 0.26 | 27 / 183 |
kidney | 20% | 11.31 | 18 / 89 | 5% | 0.26 | 48 / 901 |
blood vessel | 10% | 6.26 | 139 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.08 | 3 / 45 |
heart | 6% | 3.76 | 50 / 861 | 0% | 0 | 0 / 0 |
liver | 2% | 1.49 | 4 / 226 | 1% | 0.01 | 3 / 406 |
muscle | 1% | 0.36 | 6 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.04 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042147 | Biological process | retrograde transport, endosome to Golgi |
GO_0034314 | Biological process | Arp2/3 complex-mediated actin nucleation |
GO_0051127 | Biological process | positive regulation of actin nucleation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0048511 | Biological process | rhythmic process |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0070534 | Biological process | protein K63-linked ubiquitination |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0030904 | Cellular component | retromer complex |
GO_0005768 | Cellular component | endosome |
GO_0005829 | Cellular component | cytosol |
GO_0005769 | Cellular component | early endosome |
GO_0005634 | Cellular component | nucleus |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | MAGEL2 |
Protein name | MAGE-like protein 2 (Necdin-like protein 1) (Protein nM15) MAGEL2 protein |
Synonyms | NDNL1 |
Description | FUNCTION: Probably enhances ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases, possibly through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. Acts as a regulator of retrograde transport via its interaction with VPS35. Recruited to retromer-containing endosomes and promotes the formation of 'Lys-63'-linked polyubiquitin chains at 'Lys-220' of WASHC1 together with TRIM27, leading to promote endosomal F-actin assembly . Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-BMAL1 heterodimer. Significantly promotes the cytoplasmic accumulation of CLOCK (By similarity). . |
Accessions | ENST00000673192.1 Q6P3U4 Q9UJ55 ENST00000650528.1 Q05BN9 Q2M1Q7 ENST00000672700.1 |